Endoxifen Methods And Compositions

Patent No. EP2101731 (titled "Endoxifen Methods And Compositions") was filed by Jina Pharmaceuticals on Nov 21, 2007. The application was issued on Jan 31, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BAYEROct 31, 2018MAIWALD
BESINS HEALTHCARE MONACO SAMOct 29, 2018NEDERLANDSCH OCTROOIBUREAU

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2101731

JINA PHARMACEUTICALS
Application Number
EP07871563A
Filing Date
Nov 21, 2007
Status
Revoked
May 19, 2023
Publication Date
Jan 31, 2018